Novo Holdings Nkarta, Inc. Transaction History

Novo Holdings

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.27 - $18.39 $16.6 Million - $25 Million	-1,356,800 Reduced 62.24%	823,200 $10.8 Million
Q2 2022 Aug 15, 2022	SELL	$7.77 - $19.44 $4.77 Million - $11.9 Million	-613,863 Reduced 21.97%	2,180,000 $26.9 Million
Q1 2022 May 16, 2022	SELL	$8.66 - $14.99 $8 - $14	-1 Reduced -0.0%	2,793,863 $31.8 Million
Q3 2020 Nov 16, 2020	BUY	$23.52 - $47.9 $65.7 Million - $134 Million	2,793,864 New	2,793,864 $84 Million

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.